Catalyst Wire Dossier Catalyst Wire Dossier

Vytorin

ezetimibe/simvastatin · Merck & Co
Drug timelines are a Plus or Pro feature.

55 regulatory and trial events tracked for Vytorin, covering 2006-07-03 to 2024-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122) [Phase 3]

See pricing